BCR and neoplasm: We performed BCR repertoire sequencing on 27 metastatic tumor biopsy samples obtained through warm autopsies of eight participants with therapy-resistant metastatic breast cancer to identify B cell clonality, isotype usages and clonal diversification across the metastases (Fig. 1 and Supplementary Table 1).